Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy

Author： Liao Chun-Ta

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.18, Iss.9, 2011-09, pp. : 2569-2578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Retrospective Cost-effectiveness Analysis of Interferon as Adjuvant Therapy in High-risk Resected Cutaneous Melanoma

By Messori A. Becagli P. Trippoli S. Tendi E.

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1373-1379

Elsevier

Access to resources Recommend Favorite

High-risk localized prostate cancer: primary surgery and adjuvant therapy

By Skinner E.C. Glode L.M.

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 219-227

Elsevier

Access to resources Recommend Favorite

Identification of highrisk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 659-666

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos Papakostas Pavlos Timotheadou Eleni Aravantinos Gerasimos Bamias Aristotelis Fountzilas George

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

By Buchholz Thomas

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 53-55

Informa Healthcare

Access to resources Recommend Favorite